Skip to content
10-Q

Quarterly Report

DarioHealth Corp. DRIO

0001104659-26-059676

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 12, 2026 7.31M sh
Shares Diluted Q1 2026 · Mar 31, 2026 6.58M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 2.37M sh
Capex Q1 2026 · Mar 31, 2026 $31K
Capex Q1 2026 · Mar 31, 2025 $31K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$6.03M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$6.67M
Long Term Debt Q1 2026 · Mar 31, 2026 $30.93M
Long Term Debt Q1 2026 · Dec 31, 2025 $30.75M
Short Term Investments Q1 2026 · Mar 31, 2026 $5.04M
Short Term Investments Q1 2026 · Dec 31, 2025 $4.21M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $14.98M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $21.8M
Stockholders Equity Q1 2026 · Mar 31, 2026 $62.38M
Stockholders Equity Q1 2026 · Dec 31, 2025 $67.92M
Stockholders Equity Q1 2026 · Mar 31, 2025 $73.7M
Stockholders Equity Q1 2026 · Dec 31, 2024 $72.02M
Current Liabilities Q1 2026 · Mar 31, 2026 $9.36M
Current Liabilities Q1 2026 · Dec 31, 2025 $9.32M
Current Assets Q1 2026 · Mar 31, 2026 $28.73M
Current Assets Q1 2026 · Dec 31, 2025 $35.07M
Total Assets Q1 2026 · Mar 31, 2026 $103.28M
Total Assets Q1 2026 · Dec 31, 2025 $110.08M
Eps Diluted Q1 2026 · Mar 31, 2026 $1.25
Eps Diluted restated Q1 2026 · Mar 31, 2025 $2.87
Eps Basic Q1 2026 · Mar 31, 2026 $1.25
Eps Basic restated Q1 2026 · Mar 31, 2025 $2.87
Sga Expense Q1 2026 · Mar 31, 2026 $3.23M
Sga Expense Q1 2026 · Mar 31, 2025 $3.31M
Rd Expense Q1 2026 · Mar 31, 2026 $2.39M
Rd Expense Q1 2026 · Mar 31, 2025 $4.11M
Net Income Q1 2026 · Mar 31, 2026 −$8.25M
Net Income Q1 2026 · Mar 31, 2025 −$9.23M
Operating Income Q1 2026 · Mar 31, 2026 −$7.31M
Operating Income Q1 2026 · Mar 31, 2025 −$9.41M
Gross Profit Q1 2026 · Mar 31, 2026 $3.2M
Gross Profit Q1 2026 · Mar 31, 2025 $3.88M